Proton versus photon radiation therapy for patients with high‐risk neuroblastoma: The need for a customized approach

Abstract

For most patients (11/13), proton therapy offered the optimal combination of target coverage and organ sparing, and is a feasible treatment for HR-NBL. We recommend a customized approach with careful evaluation of renal dosimetry; IMXT may be preferred for select patients.